318 related articles for article (PubMed ID: 31213212)
1. Toward specific ways to combine ketamine and psychotherapy in treating depression.
Hasler G
CNS Spectr; 2020 Jun; 25(3):445-447. PubMed ID: 31213212
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of ketamine action as an antidepressant.
Zanos P; Gould TD
Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
[TBL] [Abstract][Full Text] [Related]
3. Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
Kokane SS; Armant RJ; Bolaños-Guzmán CA; Perrotti LI
Behav Brain Res; 2020 Apr; 384():112548. PubMed ID: 32061748
[TBL] [Abstract][Full Text] [Related]
4. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
Kavalali ET; Monteggia LM
Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
[TBL] [Abstract][Full Text] [Related]
5. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
Miller OH; Moran JT; Hall BJ
Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
[TBL] [Abstract][Full Text] [Related]
6. Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect.
Bottemanne H; Berkovitch L; Gauld C; Balcerac A; Schmidt L; Mouchabac S; Fossati P
Neurosci Biobehav Rev; 2023 Nov; 154():105410. PubMed ID: 37793581
[TBL] [Abstract][Full Text] [Related]
7. Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders.
Lewis V; Rodrigue B; Arsenault E; Zhang M; Taghavi-Abkuh FF; Silva WCC; Myers M; Matta-Camacho E; Aguilar-Valles A
J Neurochem; 2023 Jul; 166(1):10-23. PubMed ID: 35680556
[TBL] [Abstract][Full Text] [Related]
8. Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response.
Derosa S; Misztak P; Mingardi J; Mazzini G; Müller HK; Musazzi L
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110871. PubMed ID: 37793481
[TBL] [Abstract][Full Text] [Related]
9. Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.
Kim JW; Monteggia LM
Behav Brain Res; 2020 Feb; 380():112378. PubMed ID: 31760154
[TBL] [Abstract][Full Text] [Related]
10. An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions.
Lewis V; Rurak G; Salmaso N; Aguilar-Valles A
Trends Neurosci; 2024 Mar; 47(3):195-208. PubMed ID: 38220554
[TBL] [Abstract][Full Text] [Related]
11. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
[TBL] [Abstract][Full Text] [Related]
12. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
13. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
Suzuki K; Monteggia LM
Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
[TBL] [Abstract][Full Text] [Related]
14. The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways.
Ren L
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110910. PubMed ID: 38061484
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacology of ketamine and esketamine as rapid-acting antidepressants].
Pavlidi P; Megalokonomou A; Sofron A; Kokras N; Dalla C
Psychiatriki; 2021 Dec; 32(Supplement I):55-63. PubMed ID: 34990380
[TBL] [Abstract][Full Text] [Related]
16. Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.
Thelen C; Flaherty E; Saurine J; Sens J; Mohamed S; Pitychoutis PM
Neuroscience; 2019 Feb; 398():182-192. PubMed ID: 30537521
[TBL] [Abstract][Full Text] [Related]
17. Neuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine.
Zavaliangos-Petropulu A; Al-Sharif NB; Taraku B; Leaver AM; Sahib AK; Espinoza RT; Narr KL
Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Apr; 8(4):361-386. PubMed ID: 36775711
[TBL] [Abstract][Full Text] [Related]
18. Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence.
Averill LA; Fouda S; Murrough JW; Abdallah CG
Adv Pharmacol; 2020; 89():163-194. PubMed ID: 32616206
[TBL] [Abstract][Full Text] [Related]
19. Role of the mesolimbic dopamine pathway in the antidepressant effects of ketamine.
Cardona-Acosta AM; Bolaños-Guzmán CA
Neuropharmacology; 2023 Mar; 225():109374. PubMed ID: 36516891
[TBL] [Abstract][Full Text] [Related]
20. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.
Abdallah CG; Sanacora G; Duman RS; Krystal JH
Annu Rev Med; 2015; 66():509-23. PubMed ID: 25341010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
